CervoMed Inc.
CRVO
$2.89
-$0.02-0.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -77.56% | -58.86% | -38.81% | -19.44% | 15.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -77.56% | -58.86% | -38.81% | -19.44% | 15.14% |
| Cost of Revenue | 6.23% | 15.40% | 57.54% | 96.15% | 119.74% |
| Gross Profit | -74.71% | -95.21% | -273.07% | -802.25% | -753.05% |
| SG&A Expenses | 17.57% | 14.37% | 14.77% | 11.02% | 23.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.75% | 15.51% | 41.77% | 58.50% | 77.22% |
| Operating Income | -48.57% | -55.24% | -102.01% | -128.52% | -133.09% |
| Income Before Tax | -60.88% | -65.53% | -114.15% | -348.36% | -349.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -60.88% | -65.53% | -114.15% | -348.36% | -349.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.88% | -65.53% | -114.15% | -348.36% | -349.69% |
| EBIT | -48.57% | -55.24% | -102.01% | -128.52% | -133.09% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -52.38% | -49.27% | -79.55% | -543.67% | 25.67% |
| Normalized Basic EPS | -52.36% | -49.26% | -79.53% | -543.45% | 25.67% |
| EPS Diluted | -52.38% | -49.27% | -79.55% | -47.46% | 49.33% |
| Normalized Diluted EPS | -52.36% | -49.26% | -79.53% | -437.42% | 27.65% |
| Average Basic Shares Outstanding | 5.46% | 12.01% | 19.32% | 43.40% | 114.02% |
| Average Diluted Shares Outstanding | 5.46% | 12.01% | 19.32% | 40.76% | 108.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |